145 related articles for article (PubMed ID: 9236604)
21. Genetic alterations in head and neck cancer.
Somers KD; Schechter GL
Otolaryngol Clin North Am; 1992 Oct; 25(5):1065-71. PubMed ID: 1408191
[TBL] [Abstract][Full Text] [Related]
22. Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma.
Freier K; Joos S; Flechtenmacher C; Devens F; Benner A; Bosch FX; Lichter P; Hofele C
Cancer Res; 2003 Mar; 63(6):1179-82. PubMed ID: 12649172
[TBL] [Abstract][Full Text] [Related]
23. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression.
Akervall JA; Michalides RJ; Mineta H; Balm A; Borg A; Dictor MR; Jin Y; Loftus B; Mertens F; Wennerberg JP
Cancer; 1997 Jan; 79(2):380-9. PubMed ID: 9010112
[TBL] [Abstract][Full Text] [Related]
24. Chromosome 13q deletion mapping in head and neck squamous cell carcinomas: identification of two distinct regions of preferential loss.
Maestro R; Piccinin S; Doglioni C; Gasparotto D; Vukosavljevic T; Sulfaro S; Barzan L; Boiocchi M
Cancer Res; 1996 Mar; 56(5):1146-50. PubMed ID: 8640775
[TBL] [Abstract][Full Text] [Related]
25. Molecular pathogenesis of head and neck squamous cell carcinoma.
Hardisson D
Eur Arch Otorhinolaryngol; 2003 Oct; 260(9):502-8. PubMed ID: 12736744
[TBL] [Abstract][Full Text] [Related]
26. [Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer].
Wittekindt C; Wagner S; Mayer CS; Klußmann JP
Laryngorhinootologie; 2012 Mar; 91 Suppl 1():S1-26. PubMed ID: 22456913
[TBL] [Abstract][Full Text] [Related]
27. Squamous carcinoma of the head and neck: molecular mechanisms and potential biomarkers.
Rose BR; Thompson CH; Tattersall MH; O'Brien CJ; Cossart YE
Aust N Z J Surg; 2000 Aug; 70(8):601-6. PubMed ID: 10945556
[TBL] [Abstract][Full Text] [Related]
28. Frequent novel DNA copy number increase in squamous cell head and neck tumors.
Brzoska PM; Levin NA; Fu KK; Kaplan MJ; Singer MI; Gray JW; Christman MF
Cancer Res; 1995 Jul; 55(14):3055-9. PubMed ID: 7606727
[TBL] [Abstract][Full Text] [Related]
29. Oncogene amplification in squamous cell carcinoma of the head and neck.
Merritt WD; Weissler MC; Turk BF; Gilmer TM
Arch Otolaryngol Head Neck Surg; 1990 Dec; 116(12):1394-8. PubMed ID: 2248738
[TBL] [Abstract][Full Text] [Related]
30. Deletion mapping of chromosome 4q22-35 and identification of four frequently deleted regions in head and neck cancers.
Cetin E; Cengiz B; Gunduz E; Gunduz M; Nagatsuka H; Bekir-Beder L; Fukushima K; Pehlivan D; N MO; Nishizaki K; Shimizu K; Nagai N
Neoplasma; 2008; 55(4):299-304. PubMed ID: 18505340
[TBL] [Abstract][Full Text] [Related]
31. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
Hogg RP; Honorio S; Martinez A; Agathanggelou A; Dallol A; Fullwood P; Weichselbaum R; Kuo MJ; Maher ER; Latif F
Eur J Cancer; 2002 Aug; 38(12):1585-92. PubMed ID: 12142046
[TBL] [Abstract][Full Text] [Related]
32. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma.
Callender T; el-Naggar AK; Lee MS; Frankenthaler R; Luna MA; Batsakis JG
Cancer; 1994 Jul; 74(1):152-8. PubMed ID: 8004570
[TBL] [Abstract][Full Text] [Related]
33. Frequent chromosomal aberrations and candidate genes in head and neck squamous cell carcinoma.
Szyfter K; Wierzbicka M; Hunt JL; Rinaldo A; Rodrigo JP; Takes RP; Ferlito A
Eur Arch Otorhinolaryngol; 2016 Mar; 273(3):537-45. PubMed ID: 25355032
[TBL] [Abstract][Full Text] [Related]
34. [Molecular aspects of head and neck, and lung cancer oncogenesis].
Loriot Y; Mordant P; Fouret P; Deutsch E; Soria JC
Bull Cancer; 2009; 96 Suppl 1():S13-24. PubMed ID: 19433370
[TBL] [Abstract][Full Text] [Related]
35. [Molecular cytogenetic characterization of squamous cell carcinoma of the head and neck region].
Bockmühl U
Laryngorhinootologie; 2000 Apr; 79(4):249-50. PubMed ID: 10838691
[No Abstract] [Full Text] [Related]
36. Deletion and methylation of the tumour suppressor gene p16/CDKN2 in primary head and neck squamous cell carcinoma.
González MV; Pello MF; López-Larrea C; Suárez C; Menéndez MJ; Coto E
J Clin Pathol; 1997 Jun; 50(6):509-12. PubMed ID: 9378820
[TBL] [Abstract][Full Text] [Related]
37. Variability of genetic alterations in different sites of head and neck cancer.
Rodrigo JP; Suárez C; González MV; Lazo PS; Ramos S; Coto E; Alvarez I; García LA; Martínez JA
Laryngoscope; 2001 Jul; 111(7):1297-301. PubMed ID: 11568558
[TBL] [Abstract][Full Text] [Related]
38. Amplification of the int-2 gene in human head and neck squamous cell carcinomas.
Somers KD; Cartwright SL; Schechter GL
Oncogene; 1990 Jun; 5(6):915-20. PubMed ID: 2193294
[TBL] [Abstract][Full Text] [Related]
39. Cytogenetics in head and neck cancer.
Cowan JM
Otolaryngol Clin North Am; 1992 Oct; 25(5):1073-87. PubMed ID: 1408192
[TBL] [Abstract][Full Text] [Related]
40. Polymerase chain reaction-based restriction fragment length polymorphism analysis of the short arm of chromosome 3 in primary head and neck squamous carcinoma.
el-Naggar AK; Lee MS; Wang G; Luna MA; Goepfert H; Batsakis JG
Cancer; 1993 Aug; 72(3):881-6. PubMed ID: 8101470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
